Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Cell Death & Disease|September 22, 2018
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosisDavid Fernández-Ramos, Pablo Fernández-Tussy, Fernando Lopitz-Otsoa, et al.
JHEP Reports : Innovation in Hepatology|May 17, 2021
Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injuryPaula Iruzubieta, Naroa Goikoetxea-Usandizaga, Lucía Barbier-Torres, et al.
Hepatology (Baltimore, Md.)|May 18, 2024
Mitochondrial antiviral signaling protein enhances MASLD progression through the ERK/TNFα/NFκβ pathwayEva Nóvoa, Natália da Silva Lima, Maria J Gonzalez-Rellan, et al.
Hepatology Communications|November 22, 2017
Role of Aramchol in steatohepatitis and fibrosis in miceMarta Iruarrizaga-Lejarreta, Marta Varela-Rey, David Fernández-Ramos, et al.
Nature Communications|December 14, 2017
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injuryLucía Barbier-Torres, Paula Iruzubieta, David Fernández-Ramos, et al.
Gastroenterology|January 31, 2017
Metabolomic Identification of Subtypes of Nonalcoholic SteatohepatitisCristina Alonso, David Fernández-Ramos, Marta Varela-Rey, et al.
Cell Metabolism|February 22, 2020
Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride AssemblyJorge Simon, Maitane Nuñez-García, Pablo Fernández-Tussy, et al.
Cell Metabolism|February 24, 2026
Lack of PCK1 in hepatic stellate cells causes liver fibrosis by fueling tricarboxylic acid cycle and increasing glycolysisEva Novoa, Tamara Parracho, Julica Inderhees, et al.
Hepatology (Baltimore, Md.)|April 25, 2020
The L-α-Lysophosphatidylinositol/G Protein-Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and SteatohepatitisMarcos F Fondevila, Uxia Fernandez, Maria J Gonzalez-Rellan, et al.
Pageof 8